Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHENZHEN STOCK EXCHANGE  >  BGI Genomics Co., Ltd.    300676   CNE100003449

BGI GENOMICS CO., LTD.

(300676)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

BGI Genomics Co., Ltd. : half-yearly earnings release

08/24/2020 | 09:15am EST

The company will report its earnings for S1 2020 on 08/27/2020. Generally, the company reports earnings worse than estimates. In recent months, the 2 analysts from Standard & Poor's consensus have not revised their EPS estimates.


© MarketScreener.com 2020
All news about BGI GENOMICS CO., LTD.
09/23China's BGI wins 1.5 million coronavirus test kit order from Ethiopia
RE
09/23China's BGI wins 1.5 mln coronavirus test kit order from Ethiopia
RE
08/27BGI GENOMICS : WHO says it is in talks with China's BGI on test kit after Swedis..
RE
08/26BGI GENOMICS : China's BGI defends COVID-19 test kit after Swedish criticism
RE
08/24BGI GENOMICS CO., LTD. : half-yearly earnings release
08/05SPECIAL REPORT : COVID opens new doors for China's gene giant
RE
07/22BGI GENOMICS : Chinese genetics company BGI denies U.S. human rights accusations
RE
07/21U.S. adds 11 firms to economic blacklist over China's treatment of Uighurs
RE
07/20U.S. adds 11 firms to economic blacklist over China's treatment of Uighurs
RE
07/14BGI GENOMICS : China's BGI forecasts 700% jump in first-half profit due to COVID..
RE
More news
Financials
Sales 2020 8 985 M 1 366 M 1 366 M
Net income 2020 3 530 M 537 M 537 M
Net Debt 2020 - - -
P/E ratio 2020 14,5x
Yield 2020 0,15%
Capitalization 50 542 M 7 687 M 7 683 M
Capi. / Sales 2020 5,63x
Capi. / Sales 2021 9,43x
Nbr of Employees -
Free-Float 100,0%
Chart BGI GENOMICS CO., LTD.
Duration : Period :
BGI Genomics Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BGI GENOMICS CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price
Last Close Price 127,60 
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers
NameTitle
Ye Yin General Manager & Director
Jian Wang Chairman
Song Gang Li Chairman-Supervisory Board
Yi Qing Chen Chief Financial Officer
Jun Wang Director
Sector and Competitors
1st jan.Capitalization (M$)
BGI GENOMICS CO., LTD.85.74%7 687
EXACT SCIENCES CORPORATION25.29%18 427
GUARDANT HEALTH, INC.44.15%11 261
INVITAE CORPORATION190.45%8 278
ADAPTIVE BIOTECHNOLOGIES CORPORATION53.18%6 268
IOVANCE BIOTHERAPEUTICS, INC.37.07%5 565